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Abstract
Background: Over 3 million stillbirths occur annually in sub Saharan Africa; most occur intrapartum and are largely
preventable. The standard of care for fetal heart rate (FHR) assessment in most sub-Saharan African settings is a
Pinard Stethoscope, limiting observation to one person, at one point in time. We aimed to test the functionality
and acceptability of a wireless FHR monitor that could allow for expanded monitoring capacity in rural
Southwestern Uganda.
Methods: In a mixed method prospective study, we enrolled 1) non-laboring healthy term pregnant women to
wear the device for 30 min and 2) non-study clinicians to observe its use. The battery-powered prototype uses
Doppler technology to measure fetal cardiotocographs (CTG), which are displayed via an android device and
wirelessly transmit to cloud storage where they are accessible via a password protected website. Prototype
functionality was assessed by the ability to obtain and transmit a 30-min CTG. Three obstetricians independently
rated CTGs for readability and agreement between raters was calculated. All participants completed interviews on
acceptability.
Results: Fifty pregnant women and 7 clinicians were enrolled. 46 (92.0%) CTGs were successfully recorded and
stored. Mean scores for readability were 4.71, 4.71 and 4.83 (out of 5) with high agreement (intra class correlation 0.
84; 95% CI 0.74 to 0.91). All pregnant women reported liking or really liking the device, as well as high levels of
comfort, flexibility and usefulness of the prototype; all would recommend it to others. Clinicians described the
prototype as portable, flexible, easy-to-use and a time saver. Adequate education for clinicians and women also
seemed to improve correct usage and minimise concerns on safety of the device.
Conclusions: This prototype wireless FHR monitor functioned well in a low-resource setting and was found to be
acceptable and useful to both pregnant women and clinicians. The device also seemed to have potential to
improve the experience of the users compared with standard of care and expand monitoring capacity in settings
where bulky, wired or traditional equipment are unreliable. Further research needs to investigate the potential
impact and cost of such innovations to improve perinatal outcomes.
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Background
Worldwide, there are over 6.3 million perinatal deaths a
year and of these, more than 4 million are stillbirth
[1, 2]. One third of the stillbirths occur intrapartum and
are largely due to birth asphyxia. Early neonatal deaths
occur during the perinatal period, and typically have ob-
stetric origins, similar to those leading to intrapartum
stillbirths. Intrapartum stillbirths and early neonatal
deaths from intrapartum events are rare in developed
settings [3, 4]. Over 98% of these deaths take place in
the developing world, with the risk of deaths in the neo-
natal period six times greater than in developed coun-
tries and over 8 times higher in the least developed
countries [5–9].
In 2014, Uganda had a perinatal mortality rate of 40
per 1000 births [10]; 27% of these deaths resulted from
birth asphyxia attributed to inadequate critical human
resources, no action due to lack of reliable data, and/or
delay in seeking help [11]. Though controversy remains
over the benefit of continuous electronic fetal heart
monitoring for most low risk laboring women, intermit-
tent auscultation fetal monitoring is widely accepted as a
critical element of intrapartum care [12].
In Uganda, the most common approach is a Pinard’s
stethoscope (Fig. 1) used to manually listen to the pat-
tern and frequency of fetal heart beat whenever deemed
necessary. This tool has no visible corresponding trac-
ings for review and fetal heart rate is estimated by
pressing the tool firmly onto a mother’s abdomen, listen-
ing, and counting the heart beats. This method limits
routine observations to one person at one point in time,
is prone to errors, is restrictive to an examination couch
since it requires the woman to be lying down, is time
consuming and ultimately affects the continuity and fre-
quency of observations amidst a shortage of human
resource.
Innovative technology can improve efficiency of care
amidst ongoing personnel shortages. Fixed and wired
cardiotocograms (CTG) are available that provide visible
and audible data in real time; however, the technology is
immobile and has high maintenance costs [13], making
it unsuitable and unavailable in low resource settings.
With the improved availability of wireless signals in
these settings, simple, user-friendly technology utilizing
this wireless technology could overcome human re-
source challenges and improve monitoring, particularly
if alerts are inbuilt to detect abnormal values. Conse-
quently, this technology may have the potential to re-
duce the rates of perinatal deaths. Wireless fetal heart
monitors that transmit fetal heart rate data to a central
server remotely either through modems [14] or Blue-
tooth [15] have been developed to allow real-time as-
sessment of labour. Pilot studies have found the
Bluetooth technology to be acceptable and feasible to
both women and clinicians in both outpatient and in-
patient settings of developed countries [15, 16]. The re-
corded CTGs from a wireless fetal monitoring prototype
technology were also found to be easy to read generally
and the technology itself useful, likeable and recom-
mended among pregnant women in an inpatient labour
ward in USA. The wireless CTG monitoring further
seemed to be friendly, with potential to improve
outcomes.
This study set out to assess the functionality of a novel
wireless prototype for measuring fetal heart rate and
uterine contractions (cardiotocography) in a busy mater-
nity unit in rural Southwestern Uganda. Acceptability
was assessed from the perspectives of both the pregnant
women being monitored and the clinicians interacting
with the device.
Methods
Study design and setting
We conducted a cross-sectional observational study in-
volving quantitative and qualitative methods of data col-
lection at Mbarara Regional Referral Hospital, a
publically-funded teaching hospital in rural south-
western Uganda. We used a mixed methods study in-
volving documentation of device functionality, as well as
surveys to quantify acceptability and qualitative inter-
views to provide a more in depth understanding of fac-
tors related to acceptability [17]. The hospital employs
Fig. 1 A Pinard’s stethoscope in use at Mbarara Regional
Referral Hospital
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11 obstetricians and 22 midwives and performs over
10,000 deliveries annually [18] with approximately
twenty beds located in each of two wings on the ward.
Maternity departmental records of 2015 also indicate a
maternal mortality rate of 270/100,000 live birth, caesar-
ean section rate of 30% and a perinatal mortality rate of
56/1000. Although often incompletely implemented, all
mothers in labour are ideally monitored using a parto-
gram- a graph of labour parameters and cervical dilation
over time with pre-printed alert and action lines de-
signed to prompt intervention if a woman’s curve devi-
ates from the expected course. The fetal heart rate is
monitored manually per clinician judgment using the
Pinard (Fig. 1). No electronic monitors are used on this
ward, except for an ultrasound scan that is occasionally
used to confirm presence or absence of regular cardiac
pulsations, but not for monitoring labour. No wireless
internet connection is available in the ward although cel-
lular phone network coverage is available from multiple
cellular phone companies. The ward walls are made of
concrete (potential for interfering with wireless data
transmission)
Participants and recruitment
This study involved two types of participants: pregnant
women and clinical staff observing the wireless fetal
monitoring prototype. Using a convenience sample, we
screened and recruited healthy non-laboring pregnant
women, aged 18 and older, carrying a singleton gestation
estimated to be at term and admitted to MRRH. The
women were asked to wear the prototype for thirty mi-
nutes. Women who were unwilling to wear the monitor-
ing device or those with a known infectious disease or
hypersensitivity to materials found in the device were
excluded. We also recruited a convenience sample of
clinical staff to interact with the device and observe its
use on recruited pregnant women. Informed written
consent was obtained for all participants prior to enrol-
ment. The study was conducted between May 2014 and
August 2014.
Wireless fetal monitor
The use of this wireless fetal monitor prototype has been
previously described [15, 19] This device was developed
by Gary and Mary West Health Institute, San Diego,
California (Fig. 2). The device has received FDA ap-
proval for healthcare providers to use it to monitor ex-
pectant mothers and their fetuses during the antepartum
period. FDA approval for use during active labor has not
been approved. In our study we limited eligibility to
non-laboring pregnant women. This non-invasive proto-
type technology uses Doppler-based technology to assess
and record fetal heart rate combined with pressure sen-
sors to track uterine contractions. Data is then
transmitted via Bluetooth technology to a gateway device
(either smartphone or tablet) where the cardiotocogragh
is displayed and visualized in real time. In our study, we
used the Samsung Galaxy Note (GT-N7000) as the gate-
way device. Once monitoring is complete, data is then
transmitted from the gateway device to a secure web-
based server for storage or further viewing through a
web portal. Four steps are required to completely upload
monitoring data on to the server; 1) save button, 2) a
prompt to confirm completion of fetal heart rate record-
ing session, 3) submit button to enable submission of
data, 4) confirmation of data uploading on to the server
for review via password access of any device that can ac-
cess the web. Noteworthy, this study partly involves
three of the authors in the Boatin study [15].
Study procedures
All study procedures were performed by trained research
midwives and resident obstetricians. At enrollment,
study staff collected basic socio-demographic data and a
brief obstetrical history from enrolled pregnant women
using questionnaires and the medical record. The pro-
fession of the clinical staff (e.g. physician, resident,
nurse, and midwife) was also noted.
Pregnant women were then asked to wear the proto-
type for 30 min. Study staff noted any technical chal-
lenges in obtaining and transmitting the fetal
cardiotocographs. Following the monitoring session, a
study obstetrician reviewed the cardiotocograph, prior to
participant’s discharge from the study for safety, as well
as quality. Clinical management decisions were made as
per standard of care and no intervention was made on
the basis of this technology prototype output. If there
were concerns noted, they were confirmed by traditional
methods (Pinard) used on the ward. The pregnant
woman and clinical staff interacting with the device in
Fig. 2 The wireless fetal heart monitoring prototype in use at
Mbarara Regional Referral Hospital
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use were asked to complete a brief questionnaire. Data
from all questionnaires was transferred to a secure elec-
tronic database. The prototype tracings were not saved
as part of the pregnant woman’s medical record. For this
study, all women wore a pulse oximeter to allow differ-
entiation from the fetal heart rate.
Stratifying by age of the pregnant women (greater
than or less than 30 years of age) to obtain a balance
in participants, we identified five of the pregnant
women participants for a qualitative interview. We
used a convenience sample to identify seven of the
clinical staff for qualitative interviews. These inter-
views further explored the perceptions, use, likes, dis-
likes, design and possible recommendations of this
device, as guided by the technology acceptance model
Fig. 3 [20]. This interview took place immediately
after monitoring, lasted approximately 30 min in a
private space, and was digitally recorded for
transcription.
Sample size
Our study was designed as a pilot to test functionality
and feasibility. The number of participants was based on
a convenience sample in which pregnant woman and cli-
nicians were enrolled until sufficient data were obtained
to assess the study goals and additional enrolment and
data did not change study findings and interpretation.
Data analysis
Quantitative data on participant characteristics, prototype
acceptability and use were summarized and explored de-
scriptively. Functionality was defined as the ability of the
device to record a 30-min foetal cardiotocograph, upload
this data to the cloud-based server, and retrieve and re-
view the cardiotocograph. Three obstetricians rated the
cardiotocographs for tracing quality and interpretability.
Tracings were given a score from 1 to 5 (1 = difficult to
read, 5 = easy to read) and the interclass correlation was
calculated to assess agreement between raters.
Qualitative analysis
Transcripts were derived from the qualitative interviews.
Common cross-cutting categories were then generated
from these transcripts and presented in line with the
technology acceptance model.
Results
Participant characteristics
Fifty-two pregnant women were screened, of whom 50
were enrolled and 2 declined study participation. These
women were mainly primigravid and aged 20–24 years
with 22% having attained tertiary education. Other base-
line and demographic characteristics are presented in
Table 1. All seven clinicians screened were enrolled, of
whom 6 were midwives and 1 doctor. They had been
practicing for an average of 15.2 years.
Fig. 3 Technology acceptance model as applied to a wireless prototype cardiotocography technology in rural Uganda. The qualitative interviews
of both pregnant women and clinician participants informed the model; actual use will be explored in future studies
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Functionality
All of the study staff were able to obtain the fetal heart
rate and view the cardiotocographs transmitted through
the Bluetooth technology on to the smart phone. Suc-
cessful uploading of the monitoring data from the smart
phone to the server, for storage occurred 100% of the
time. The mean time from transmission to availability
on the web portal was 2.2 min (±1.7). Delays in syn-
chronizing data were mainly due to intermittent internet
connectivity. Forty-six (92.0%) CTGs were successfully
recorded and stored, while four (8%) of the CTGs were
incomplete or unclear. Concrete walls seemed to have
no effect on the wireless transmission of data.
Tracing quality
Of the 46 cardiotocographs available for rating, the mean
scores and standard deviation for readability were
4.71 ± 0.69, 4.71 ± 0.54 and 4.83 ± 0.38 (out of 5) for the
three obstetrician raters respectively. Inter-rater agreement
was high, intra class correlation 0.84 (95% CI 0.74 to 0.91).
An example of an easy-to-read and hard-to-read CTG trac-
ings is shown in Fig. 4.
Acceptability
All women reported comfort and usefulness of the wire-
less technology prototype for fetal heart monitoring and
contractions (Table 2). All women also liked the device
and would recommend it to others for use. All clinicians
found it likeable and very useful.
Perceptions about the wireless technology prototype
The opinions of both pregnant women participants and
clinicians are presented below according to the Technol-
ogy Acceptance Model (Fig. 3).
Perceived usefulness
Pregnant women participants
All women liked the technology because it helped them
to interact with their health care providers and know
more about their health and that of their babies. This
interaction seemed to facilitate women’s involvement in
management of their labour as well as boost their confi-
dence in observing and knowing that their babies were
okay and obtain help in case anything visibly wrong was
displayed.
Fig. 4 An example of a an easy-to-read and b a hard-to-read tracing
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“I loved the device a lot because I got to interact with
the midwives and doctors as they talked to me about
my health and my baby’s condition all the time,
something that has never happened to me before. In
fact, I was very confident as I was able to see my
baby’s heart beat right there on the screen and this
meant a lot to me as a mother because I knew my
baby was okay. It’s like I got to participate in the safe
delivery of my baby which means a lot to me … I was
also confident to know I could be helped if something
wrong visibly happened.”
Additionally, the device also was thought to ‘con-
stantly’ inform their care takers of their babies’ health
status, facilitating a prompt action to avoid complica-
tions in case it happened unlike the Pinard stethoscope
which was thought to be non-informative and depended
only on individual judgment from the clinician using it.
This constant information reportedly kept women re-
laxed and made them feel good being a part of the
process to deliver their babies safely.
“Unlike the other one [Pinard] which is placed on
your abdomen and the midwife just tells you that
your baby is fine and that is all without hearing
anything yourself, this device makes me feel good and
relaxed as my care takers and I are continuously able
to see and discuss how my baby is doing and take
action.”
Clinician participants
The technology was also described by clinician partici-
pants as interactive and able to facilitate or improve
team work between staff and patients. They stated that
the prototype allowed a lot of the needed flexibility and
mobility amongst their patients while posting the needed
data in real time.
“This (technology) is very interactive. It’s very useful
than any other devices I have used in my entire
practice. Information is continuously displayed for
you to see, review and promptly share it with all the
attending staff or the mother in real time … In fact,
its flexibility allows pregnant mothers to move about
their businesses during monitoring unlike the
traditional old fashioned stethoscope that needs one
to keep still, silent, physically be present on an
examination couch.”
The wireless nature of the device was further seen to
greatly ease congestion and workload that could in turn
improve labour monitoring and improve health out-
comes generally amidst the limited human resource at
the hospital. Clinicians also noted the ability of the wire-
less device to facilitate their attendance to other routine
work or more mothers simultaneously, which to them
could potentially save time and lives in the long run.
The ability of the technology to provide fast and quick
Table 1 Baseline demographics and clinical characteristics of
women enrolled for sense4baby device
Pregnant women
Characteristic n(%) or mean
(±STD)
Age
18–19 6(2)
20–24 25(50)
25–29 17(34)
30–34 2(4)
Parity
0 26(52)
1 14(28)
2 6(12)
≥3 4(8)
Gestational age in weeks 40.1 ± 1.1
Marital Status
Married 45(90)
Never Married 4 (8)
Separated/Divorced 12(1)
Occupation
Unemployed 12(24)
Self-employed/
Unskilled
23(46)
Professional 15(30)
Education
No Formal Education 2(4)
Primary Education 17(34)
Secondary Education 20(40)
Tertiary Education 11(22)
Clinician Participants
Clinician age at
enrollment
41 ± 11
>18-34 yr 2(28.6)
≥35 5(71.5)
Years in Clinical Practice at
enrollment
15.2 ± 9.5
Clinical Position
Midwife 6(85.7)
Doctor 1(14.3)
Time spent interacting with devices
1–15 min 0(0)
16–30 min 7(100)
STD = standard deviation
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documentation of fetal well-being in real time was seen
to be highly valuable in facilitating quick informed deci-
sions needed for improved health outcomes. These clin-
ician participants further and specifically likened the
device’s ability to give a permanent record in real time
to be a great accessory in medical-legal cases related to
maternal/fetal deaths and or complications.
“It really saves a lot of time, which can be used to
interact or attend to other mothers in labour or other
emergencies as you monitor them closely and
simultaneously amidst our limited human resource …
we could save time, save more lives and definitely
reduce my workload and stress. In fact, it makes my
work easier, enjoyable and manageable.”
“This device is very useful and valuable in recording
data continuously and permanently in real time. This
helps you to make quick and informed decisions
immediately to avoid many fresh still births,
compared to the stethoscope which estimates
individual rates at a time manually and plotting these
rates manually onto a partogragh in a patient’s file,
which can be very tiresome and problematic when
one forgets to do or record observations timely in
such a place with few personnel … this could also
have some protection in case of a court case involving
a perinatal deaths.”
Perceived ease of use
Pregnant women participants
Labouring women also liked the technology and thought
it was painless and light unlike the Pinard stethoscope,
which they described as uncomfortable and painful.
These perception soften encouraged them to use this
technology through the monitoring period.
“The midwife always maneuvers physically on my
abdomen to listen to the fetal heart rate several times
which causes me a lot of pain and discomfort. With
this [device], there was no pain … I also liked it
because it is not heavy on me so I can easily use it as
long as necessary.”
A sense of freedom of movement and flexibility offered by
the wireless device during labour was also greatly appreci-
ated by all women compared to the traditional method
which they described as heavy and restrictive. These
mothers also felt the device boosted their privacy, something
that helped them to have a positive mind during labour.
“this [device] is very light, allowing me to move
around freely as I am being monitored and not always
stuck here [on my bed] physically unlike the other
Table 2 Ease of use and acceptability of the prototype
Variable Pregnant women (n(%)) Clinicians
Comfort wearing the device Very comfortable 41(82) N/A
Comfortable 9(18) N/A
Neutral/ok 0(0) N/A
Somewhat bothersome 0(0) N/A
Very bothersome 0(0) N/A
Usefulness of the device Very Useful 40(80) 7(100)
Useful 10(20) 0(0)
Somewhat useful 0(0) 0(0)
Not at all useful 0 (0) 0(0)
Acceptability of device I really like it 45(90) 4(57)
I like it 5(10) 3(43)
Neutral/OK 0(0) 0(0)
I do not like it 0 (0) 0(0)
I really do not like it 0 (0) 0(0)
Recommending use to others I definitely would 49 (98) 6(86)
I wouldn’t care one way or the other 1(2) 1(14)
I definitely would not 0 (0) 0(0)
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one [Pinard] … I did not evenhave to undress here on
the general ward to be examined all the time which
makes me feel uncomfortable and sometimes
embarrassed. Instead, I was able to relax, move
around as I waited for the delivery of my baby.”
Clinician participants
All clinician participants described the device as port-
able, convenient and non-invasive. They also felt it was
easy-to-use and with no need for specialized skill or
training to successfully install and use. Its non-invasive
and easy-to-use nature was further said to be appealing
to clinicians. According to a senior midwife,
“I like the fact that it is simple to learn by everyone,
light, portable, convenient and easy to use on
someone and it does not take a lot of time or skill to
learn or set up. The fact that it is a non-invasive de-
vice also makes it very appealing and easy to use.”
Attitude
Pregnant women participants
According to the women, the device was thought to be
well designed, comfortable and ‘very re-assuring’ since it
indicated the fetal heart rate on the screen in real time
for them to see. This to them was very fulfilling.
“I like the design because it is tied comfortably
around my abdomen, so close to the baby so it gives
very close and accurate information about my baby’s
condition inside for everyone to see. This for me is
very fulfilling and re-assuring. I like it a lot.”
Women reported that the device’s wireless nature
andinteractive attributes reduced anxiety about the ‘un-
known’. Their sense of feeling that ‘everything was al-
ways visible and under control’ seemed to be an
additional reassurance for many women.
“My anxiety reduced while I used this device since I
did not have to worry about anything bad happening
to me or my baby unknowingly…For the first time, I
could see my babies’ heart beat all the time and
interact with midwives and doctors whenever I
wanted. This really gave me the reassurance and
courage to be strong and go about doing my other
things knowing my baby was okay and everything was
visible and under control.”
A few women however expressed some concerns
about safety and hygiene of the device. According to one
mother for example,
“I know some women may be worried about possible
radiations in the device…they could also be worried
about some belts being worn by many women
without adequate cleaning.”
Clinician participants
Clinicians thought the technology prototype was accurate
and dependable in making objective and correct clinical
conclusions in real time that in turn could ease workload
and improve health outcomes in the long run. The de-
vice’s consistency and ability to detect and record any ab-
normal variations in fetal heart rate in real time was seen
to encourage quick informed decisions to avert complica-
tions and or deaths. According to a senior obstetrician,
“The readings are accurate and dependable. It gives us
results in real time throughout the monitoring period,
inclusive of abnormal variations in fetal heart rates
which obviously helps us to make prompt informed
decisions. This is very key in successful management
of labour, besides, the added time and workload
involved in investigating false alarms or late
complications are generally minimized.”
Some clinician participants thought that the device’s
flexibility, non-invasive and wireless nature gave women
a sense of comfort and a peace of mind that could facili-
tate good health outcomes.
“I don’t have to call up mothers all the time for
examination. Since its non-invasive wireless technology,
she can remain relaxed in her bed as she is being moni-
tored and this comfort in its use gives mothers a peace
of mind while going through labour which is good.”
Other clinicians observed that the wireless device pro-
moted continuous information sharing, discussion, im-
proved team work and this was seen to have the ability
to greatly improve the work experience amongst the staff
and laboring women.
“We are few midwives here and we struggle a lot
using the old fashioned Pinard to monitor all these
mothers in labour. I am sure if all midwives had
access to this device with continuous information
sharing and discussion, I know it would lessen our
work load, promote team work amongst us and
inform our timely decisions…Every woman that
comes here could go away healthy, with a healthy
baby, something which is absolutely fulfilling as a
midwife.”
Other health care providers thought the device could
be liable to inconsistencies, sometimes providing poor
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or no readings at all especially when confronted with
dead/uncharged batteries and internet connectivity
problems. A senior house officer noted,
“I think the device will give me correct and accurate
data only if the phone is well charged and the device
is well connected. This means always charging the
phone and having data on the internet to be able to
work effectively.”
Behavioral intention to use the device
Pregnant women participants
The pregnant women participants expressed an interest
in using the device with proper explanation of the tech-
nology. The device’s perceived ability to always ‘tell what
is happening with the unborn baby’ seemed to positively
influence its utility. Its use of Bluetooth technology,
which was known to many women, also seemed to add a
sense of safety among the users.
“If the nurse explains to them [women] clearly how
the device works and its use, I am sure many of us
will like to use it a lot because it works for our own
good by always telling you what is happening with our
babies…besides, it uses Bluetooth just like my phone
here and so I think it’s safe.”
The device’s perceived ease of use through its ability
to encourage ambulation of pregnant women through its
wireless connection seemed to greatly encourage its
good uptake and use among the pregnant women.
“It did not have fixed wires attached to me all over
the place, neither was I stuck to one place. I was able
to freely move around during my labour without any
problems. I think this would make it easy for me to
use it always”.
Clinician participants
All clinicians combined perceptions of ease of use and
usefulness to describe the device’s high utility value and
their intention to use the prototype. According to a se-
nior obstetrician for example,
“It’s very simple, portable and generally easy-to-use…
It’s definitely commendable and looks like one I can use
any day any time as it makes my work easier and bear-
able…every doctor or midwife would definitely appreci-
ate its output and always use it if it was available.”
However, a few clinicians felt that some mothers could
be bothered about the safety of the device and its effects
to their unborn babies if not sensitized well, which could
in turn increase anxiety.
“Some of the mothers may be anxious about the
safety of these new electronic gadgets…but I think
many will definitely like it and accept to wear it when
well sensitized about its [device] safety since it also
uses Bluetooth [technology] that is known to many
people here”
Additionally, some clinicians expressed concerns about
the device’s inability to allow storage at the gateway
stage, limiting them to review the tracings displayed on
the smart phone continuously only within the recom-
mended distance from the Bluetooth-enabled technology
as opposed to reviews online only after data is success-
fully secured on the server.
“Working on this our big ward with very few staff is
difficult. I may be attending to mothers on the other
side where the Bluetooth on my phone doesn’t pick
any signals from the device directly unless recorded
data is saved online first…that way, I may not be able
to see any tracings in real time wherever I am and act
accordingly in case of a serious problem”.
Discussion
We demonstrated the functionality and acceptability of a
novel wireless monitoring device for measuring foetal
heart rate and uterine contractions amongst pregnant
women and health care workers at a publically-funded
teaching hospital in rural south-western Uganda. We
found that over 90% of CTGs were successfully recorded
and stored within two minutes. Importantly, we found
high readability and high inter-individual agreement on
the quality of the tracings. We observed that all women
liked the prototype and described it as comfortable, flex-
ible and useful and would therefore recommend it to
others. We also observed corresponding reports from
clinicians who described the prototype as portable, flex-
ible, easy-to-use, fast, accurate and dependable. They felt
it presents an important opportunity to save time, facili-
tate prompt informed decisions and ease their work load
in such a resource constrained setting. However, proto-
type safety, battery issues and regular internet connectiv-
ity to enable constant availability of tracings were noted
by both clinicians and women as concerns if the tech-
nology were rolled out.
Like a prior study done in a USA inpatient obstetric
setting [15] we found high acceptability, desirability and
functionality of the prototype in both the pregnant
women and clinicians. Additionally, all women in this
prior study also seemed to like the great comfort, privacy
and mobility that the wireless fetal heart monitor offered
them during labour, suggesting promising desirability
and uptake. However, there were major differences.
Whereas clinicians and pregnant women’s experiences
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compared immobile/wired CTGs and wireless technol-
ogy prototype in a USA setting [15], our participants’ ex-
periences compared the prototype with the routinely
used Pinard stethoscope. Our study was also conducted
among relatively healthy full-term pregnant women car-
rying singleton gestations in latent labour admitted to a
rural resource limited maternity ward in south western
Uganda. Whereas the USA study noted design (for ex-
ample; “small screen for older eyes”, small size) as one of
the major concerns for women users, all participants in
our study seemed to like the design, with major con-
cerns noted as safety, battery issues and intermittent
internet connectivity problems that would affect timely
and continuous transmission and display of data. Con-
nectivity problems with this network-enabled technology
have previously been reported but were remedied by en-
abling the queued data to appropriately be uploaded
once a good signal was available [15]. In our study, de-
lays in synchronizing data happened once a week on
average and were overcome using pre-paid airtime on
multiple network SIM cards inserted in a study smart
phone to buy and secure data bundles, which minimized
delays mainly because of its current network consistence
in connectivity locally. Use of the SIM cards avoided
interference reported by our US sister study, which used
a general hospital Wi-Fi system [15].
Noteworthy from this study, was the perceived inter-
active nature of the technology that facilitated continu-
ous discussions of the participants’ and their babies’
wellbeing with their clinicians, a practice that is gener-
ally uncommon in Uganda. This ongoing involvement in
the management of their labor, facilitated by the dis-
played tracings from this technology seemed to have cre-
ated a sense of satisfaction and feelings of ‘constant
awareness’ from its use compared to a routine sense of
‘fear of the unknowns’ reportedly emanating from trad-
itional methods. This overall perceived usefulness of the
prototype therefore seemed to keep the laboring women
confident, relaxed and positive minded and could there-
fore pose a great opportunity for its high uptake. How-
ever, as expected from introduction of any new
technologies, safety concerns were noted by clinicians
and pregnant women, which seemed to be diminished
through careful sensitization and training prior to use.
The technology used in the prototype functioned
well in a low-resourced setting. The Bluetooth tech-
nology, which is widely available, seemed to minimize
perceived safety concerns from pregnant women and
clinicians. The transmission time was consistently
short with reliable connectivity using two cellular net-
works in the study phone interchangeably. One prob-
lem, however, was the fact that the prototype
interface did not allow for storage at the gateway
stage for clinicians to review. In a non-research busy
labour ward, a clinician may have difficulty staying
near the device to observe the CTGs displayed on the
smart phone in real time. Boatin and colleagues rec-
ommended real time transmission of the CTG from
the gateway to a central monitor as a potential means
for resolving this problem, which could also poten-
tially work in this setting [15].
Our study has important strengths. First, it documents
novel perspectives of pregnant women and clinicians on
the acceptability and functionality of this prototype tech-
nology in a rural low- resourced setting, which has not
been studied before. Second, the mixed methods design
(including quantitative and qualitative aspects) provides
a rich and deep understanding of the issues involved
with technology uptake.
We believe that the usefulness of a device depends on
both the perspectives of the care providers and the pa-
tients. Indeed, no device will be used in practice if pa-
tients object to it. Moreover, other studies have taken
similar approaches to studying technology acceptance
[21, 22]. Several limitations were also observed in our
study. First, the small sample size could affect the gener-
alisability of the findings, although we found consistency
in both the quantitative and qualitative findings.
Whereas this study demonstrates potential for the wire-
less foetal monitoring to be greatly acceptable in an in-
patient low resource setting, we only assessed a 30-min
period per pregnant woman. Additional study with inte-
gration of the technology into day-to-day work flows is
needed. Importantly, we also did not assess clinical
benefit in preventing or mitigating poor foetal outcomes,
which should be explored now that the functionality and
acceptability of this prototype technology have been
demonstrated.
Conclusions
This wireless prototype cardiotocograph functioned well
in a low-resourced setting and was found to be accept-
able and useful to both pregnant women and clinicians.
The device also had potential to improve the experience
of the users and expand monitoring capacity compared
with standard of care. This study is the first to our
knowledge that demonstrates the use of a wireless cardi-
otocograph in a low resource setting. It is also the first
study to query acceptability of such a device among pa-
tients and clinicians in a low resource context. Our
study demonstrated that this novel wireless prototype
cardiotocograph functioned well and was acceptable and
useful to both pregnant women and clinicians, with po-
tential of improving the experience of the users. This de-
vice will potentially expand monitoring capacity
compared with standard of care especially in resource
constrained environment. Further research needs to
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investigate the potential impact and cost of such innova-
tions to improve perinatal outcomes.
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